Table 1.

Population pharmacokinetic parameters and statistical results, two-compartment model, following the administration of ¹³¹I-mAbF19 to cancer patients.

Parameter	Population mean value	Standard error of estimate	Intersubject variability (CV)	Standard error of variability estimate
CL (ml h−1)	109	14.6%	54%	31%
Q (ml h−1)	142	18.2%	a	a
V (l)	3.13	10.8%	37%	49%
Vss (l)	4.87	9.2%	31%	45%
Residual variability	12.5%			31%

^anot in final model.